IMMX Immix Biopharma, Inc.
Healthcare$8.78+1.27%ClosedMarket Cap: $477.7M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$17.00
Target (Median)
$17.00
Target Range
$14.00 - $20.00
Upside from current price: 93.6%
Rating Distribution
2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-30 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-27 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-12-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-12 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-04 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.65 | $56.4M | 2 |
| Sun Dec 31 | $-0.20 | $205.5M | 1 |
| Mon Dec 31 | $0.29 | $332.1M | 1 |
| Tue Dec 31 | $1.78 | $481.6M | 1 |